Clinical Trial Update: Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma [Phase 1]

View source ↗

Summary

Pilot Phase 1 study evaluating imatinib (Gleevec) for advanced thymic carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Thymic Carcinoma | Phase 1 | Status: COMPLETED